Concepedia

F Jost

FJ

Statistics

Publications

4

Citations

343

H-Index

4

Active since

2005

Affiliations

Roche (Switzerland)(Current)

F Jost is an author at Roche (Switzerland) specializing in rituximab-based therapy, response assessment, and pharmacotherapy.

Publications per year

2005–2009

4

Publications

4

German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus

J.-Matthias Graf von der Schulenburg, Wolfgang Greiner, F Jost et al. · Value in Health · 2008 · 173 citations

, , +17

Improvement in patient‐reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy

Edward Keystone, Gerd R Burmester, R. Furie et al. · Arthritis Care & Research · 2008 · 106 citations

, , +17

Cost-Effectiveness Analysis of Rituximab Combined with CHOP for Treatment of Diffuse Large B-Cell Lymphoma

Jennie H. Best, John Hornberger, Stephen J. Proctor et al. · Value in Health · 2005 · 48 citations

, , +5

A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma

R. E. Marcus, R Aultman, F Jost · British Journal of Cancer · 2009 · 16 citations · Full text

, , +13

1–4 of 4